Edwards Lifesciences (EW) Tops Q1 EPS by 10c; Issues Mixed Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Northland Capital Markets Downgrades Edwards Lifesciences (EW) to Market Perform
April 25, 2018 8:12 AM EDTNorthland Capital Markets downgraded Edwards Lifesciences (NYSE: EW) from Outperform to Market Perform with a price target of $120.00.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $134.67 yesterday.
... MoreEdwards Lifesciences (EW) PT Lowered to $145 at Evercore ISI
April 25, 2018 6:40 AM EDTEvercore ISI lowered its price target on Edwards Lifesciences (NYSE: EW) to $145.00 (from $151.00) while maintaining an Outperform rating following results.
... More